Wealth Enhancement Advisory Services, LLC Tg Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $61.1 Billion
- Q3 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 19,747 shares of TGTX stock, worth $598,334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,747Holding current value
$598,334% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
400Shares Held
90.7MCall Options Held
2.28MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA15.5MShares$470 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$345 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$231 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$106 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$92.5 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.4B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...